Ledger.Open graph →
SEC Form D · filed January 24, 2020

Eureka Therapeutics, Inc

Offering
$45.0M
Sold
$45.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Emeryville, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Bo D. Feng · Emeryville, CADirectorWai-Yan "Sandy" D. Chau · Emeryville, CADirectorCheng Liu · Emeryville, CAExec · DirectorVictor S. Shum · Emeryville, CAExecChih-Kai "C.K." D. Cheng · Emeryville, CADirectorMichael D. Cannon · Emeryville, CADirectorJacqueline S. Northcut · Emeryville, CADirectorMarvin T. Samson · Emeryville, CADirectorJohn Gu · Durham, NCDirectorC. V. Lal · Birmingham, ALDirectorGreg Dolan · Durham, NCExec · DirectorJohn Busbice · Durham, NCExecWesley R. Wilson · Irvine, CADirectorAmrik V. Walia · Birmingham, ALDirectorWilliam S. Solari Iii · Emeryville, CADirectorVivien S. Chan · Emeryville, CAExecMamoon Hamid · SAN FRANCISCO, CADirectorLeigh A. Cagan · Madison, WIDirectorWilliam A. Henrickson · Madison, WIDirectorDaniel C. Ludois · Madison, WIExecJustin K. Reed · Madison, WIDirectorCarey H. Peters · Boise, IDExec · DirectorJacqueline S. Northcut · Emeryville, CADirectorMarvin T. Samson · Emeryville, CADirectorWilliam S. Solari Iii · Emeryville, CADirectorVivien S. Chan · Emeryville, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗